Precision Medicine News and Research

RSS

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

An EU-funded project has developed a blood-cell analysis device that helps doctors and scientists better understand the causes and mechanics of rare forms of anemia - potentially speeding up the development of new treatments adjusted to the needs of patients with these diseases.

25 Apr 2019

Blood test can help match cancer patients to early phase clinical trials

Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines, by analyzing the genetic faults in a sample of their blood, according to research published in Nature Medicine today (Monday).

23 Apr 2019

Treating cancer patients with personalized, combination therapies improves outcomes

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor.

23 Apr 2019

Scientists deploy CRISPR gene-editing tool to engineer multiple edits

Scientists at Christiana Care Health System's Gene Editing Institute and NovellusDx, an Israeli biotechnology company, have deployed a breakthrough CRISPR gene-editing tool to successfully engineer multiple edits simultaneously to fragments of DNA extracted from a human cell, according to a new study published today in The CRISPR Journal.

19 Apr 2019

Online atlas created to identify, classify protein signatures present at AML diagnosis

Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis.

17 Apr 2019

Study uncovers new biomarker for personalized cancer treatments

Cancer cells are characterized by the ability to evade apoptosis, a type of programmed cell death that allows the organism to remove damaged cells.

16 Apr 2019

Statins provide no benefit for 50 percent of patients, say researchers

Millions of patients do not benefit from taking statins and fail to achieve a cholesterol level low enough to reduce their risk of heart or stroke, report researchers.

16 Apr 2019

Precise decoding of breast cancer cells paves way for new treatment option

Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over one hundred breast tumors.

16 Apr 2019

Neuronal transport factor detects its target transcripts in more complex manner than previously thought

A team of scientists from Helmholtz Zentrum München and the University of Ulm has discovered that the neuronal transport factor Staufen2 scans and binds to its target transcripts in a much more complex manner than previously thought.

16 Apr 2019

Discovery of biomarkers could lead to new, better treatment options for heart disease

Coronary heart disease is a leading cause of death worldwide, but identifying those at high risk remains difficult. EU-funded research has helped identify new biomarkers that will improve diagnosis and lead to new and better treatment options.

12 Apr 2019

FDA approves new treatment for adults with metastatic bladder cancer

The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration known as FGFR3 or FGFR2, and that has progressed during or following prior platinum-containing chemotherapy.

12 Apr 2019

Study describes vulnerability shared by large subset of cancer cell lines

Cancer cells adapt to potentially fatal mutations and other molecular malfunctions by adjusting one or more other genes' activity, in the process becoming dependent on those genes for their survival and growth.

12 Apr 2019

Large-scale screen efficiently identifies drugs that are potent cancer-killers

UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone.

10 Apr 2019

High Throughput Nucleic Acid Purification Simplified

Labs demand purity and flexibility for high throughput nucleic acid purification, while needing to complete difficult downstream analysis, for example NGS.

From Promega Corporation 9 Apr 2019

Biologists analyze available methods of targeted drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University analyzed available methods of targeted drug delivery to malignant tumors.

9 Apr 2019

Study of MS patients shows 18% were given wrong diagnoses

A recent study found that nearly 18 percent of patients diagnosed with multiple sclerosis before being referred to two major Los Angeles medical centers for treatment actually had been misdiagnosed with the autoimmune disease.

8 Apr 2019

Digital Integration in Laboratory Practice Highlighted in LABVOLUTION 2019

LABVOLUTION is a product of BIOTECHNICA and saw its debut in 2015. Now, gearing up to launch its 2019 show, LABVOLUTION is Europe’s flagship lab tech trade event.

8 Apr 2019

Embryo selection for IVF can be optimized using artificial intelligence technique

A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy.

5 Apr 2019

AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research

On Friday, March 29 to Wednesday, April 3, the Georgia World Congress Center in Atlanta, Georgia, hosted the AACR Annual Meeting 2019.

From 10x Genomics, Inc. 4 Apr 2019

DBS improves patients' cognitive control by increasing power of brain rhythms

In a new study that could improve the therapeutic efficacy of deep-brain stimulation for psychiatric disorders such as depression, a team of scientists shows that, when DBS is applied to a specific brain region, it improves patients' cognitive control over their behavior by increasing the power of a specific low-frequency brain rhythm in their prefrontal cortex.

4 Apr 2019

Precision Medicine News and Research

New blood-cell analysis device helps better understand causes and mechanics of rare anemia

Blood test can help match cancer patients to early phase clinical trials

Treating cancer patients with personalized, combination therapies improves outcomes

Scientists deploy CRISPR gene-editing tool to engineer multiple edits

Online atlas created to identify, classify protein signatures present at AML diagnosis

Study uncovers new biomarker for personalized cancer treatments

Statins provide no benefit for 50 percent of patients, say researchers

Precise decoding of breast cancer cells paves way for new treatment option

Neuronal transport factor detects its target transcripts in more complex manner than previously thought

Discovery of biomarkers could lead to new, better treatment options for heart disease

FDA approves new treatment for adults with metastatic bladder cancer

Study describes vulnerability shared by large subset of cancer cell lines

Large-scale screen efficiently identifies drugs that are potent cancer-killers

High Throughput Nucleic Acid Purification Simplified

Biologists analyze available methods of targeted drug delivery to malignant tumors

Study of MS patients shows 18% were given wrong diagnoses

Digital Integration in Laboratory Practice Highlighted in LABVOLUTION 2019

Embryo selection for IVF can be optimized using artificial intelligence technique

AACR Annual Meeting 2019 Highlighted Latest Advances in Cancer Research

DBS improves patients' cognitive control by increasing power of brain rhythms

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News